Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

A Safety and Tolerability Study of Peginesatide in Anemic Cancer Patients Receiving Cytotoxic Chemotherapy.

This study has been terminated.
(Due to the uncertain regulatory landscape for erythropoiesis-stimulating agents in oncology indications.)
Information provided by (Responsible Party):
Takeda Identifier:
First received: February 26, 2008
Last updated: November 29, 2011
Last verified: November 2011
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: June 2008
  Primary Completion Date: June 2008 (Final data collection date for primary outcome measure)